ReadyGo™ and Gemina reach significant milestone
ReadyGo Diagnostics Ltd. and Gemina Laboratories Ltd. have achieved a significant milestone in their collaboration. They have successfully demonstrated the feasibility of using saliva as a sample for detecting Mycobacterium Tuberculosis (MTB), a highly contagious airborne disease.
This breakthrough development has the potential to revolutionise TB detection efforts, especially in countries like India and Indonesia where the disease is prevalent.
Currently, many cases of MTB go undiagnosed and untreated due to limitations in existing diagnostic methods. The collaboration aims to develop a saliva-based MTB Screening Test using the Geo platform, a low-cost fluorescence device that enables molecular diagnostics outside of the laboratory. The objective is to launch the test in 2024, providing quick and affordable results within 30 minutes.
Additionally, the team plans to introduce a compact laboratory instrument priced below $1000, with a per-test cost of $5, facilitating field testing near patients.